GHK-Cu

Moderate Evidence

What Is GHK-Cu?

GHK-Cu, also known as Copper Peptide GHK-Cu or Copper Tripeptide-1, is a naturally occurring tripeptide composed of three amino acids — glycine, histidine, and lysine — bound to a copper(II) ion. First identified in human plasma by Dr. Loren Pickart in 1973, GHK-Cu was discovered when researchers observed that plasma from young individuals (aged 20-25) could stimulate aged liver tissue to produce proteins characteristic of younger tissue, while plasma from older individuals (aged 60-80) could not [1].

The concentration of GHK-Cu in human plasma declines significantly with age. At age 20, plasma levels are approximately 200 ng/mL; by age 60, levels drop to approximately 80 ng/mL [2]. This age-related decline, combined with the peptide’s documented biological activities, has positioned GHK-Cu as one of the most extensively studied peptides in the context of skin ageing and tissue remodelling.

Unlike many peptides discussed in the recovery and performance space, GHK-Cu has a well-established presence in the cosmetics industry. Copper Tripeptide-1 is a recognised cosmetic ingredient found in hundreds of commercially available skincare products worldwide. This commercial history has generated a substantial body of research, including human studies on topical applications, giving GHK-Cu a stronger evidence base than many other peptides.

The peptide’s small size (just three amino acids with a molecular weight of 403.93 Da) contributes to its favourable skin penetration characteristics when applied topically, which is one reason it has been successfully formulated into cosmetic products.

Mechanism of Action

GHK-Cu’s biological activities appear to be mediated through multiple mechanisms, many of which are well-characterised in the research literature:

Copper delivery and metalloenzyme activation. The copper(II) ion bound to GHK plays a critical role in its biological activity. Copper is an essential cofactor for numerous enzymes involved in tissue repair and remodelling, including lysyl oxidase (required for collagen and elastin cross-linking), superoxide dismutase (antioxidant defence), and tyrosinase [3]. GHK-Cu may function in part as an efficient copper delivery vehicle to cells and tissues.

Gene expression modulation. Comprehensive gene expression studies have revealed that GHK-Cu may influence the expression of a remarkably broad set of genes. A landmark study by Pickart et al. (2012) using the Broad Institute’s Connectivity Map database found that GHK-Cu appeared to modulate the expression of over 4,000 human genes — roughly 6% of the human genome [4]. The affected genes were associated with diverse processes including collagen synthesis, antioxidant defence, DNA repair, anti-inflammatory signalling, and tissue remodelling.

Collagen and glycosaminoglycan synthesis. Research indicates that GHK-Cu may stimulate the production of collagen types I and III, the primary structural proteins of skin dermis. Studies also suggest it may promote the synthesis of glycosaminoglycans such as hyaluronic acid and dermatan sulfate, which are essential components of the extracellular matrix and contribute to skin hydration and elasticity [5].

Metalloproteinase regulation. GHK-Cu appears to modulate the activity of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). Research suggests it may both promote the controlled breakdown of damaged collagen through specific MMPs and simultaneously support the synthesis of new, properly organised collagen — essentially facilitating extracellular matrix remodelling rather than simple degradation [6].

Anti-inflammatory and antioxidant activity. Studies indicate that GHK-Cu may suppress the production of pro-inflammatory cytokines such as TGF-beta and TNF-alpha, while simultaneously upregulating antioxidant enzymes including superoxide dismutase and glutathione peroxidase [7]. This dual anti-inflammatory and antioxidant activity may contribute to its apparent protective effects on ageing tissues.

Stem cell attraction. Some research suggests that GHK-Cu may act as a chemoattractant for mesenchymal stem cells, potentially directing repair cells to sites of tissue damage [8]. This mechanism, if confirmed, could explain some of the wound healing effects observed in studies.

Research and Evidence

Skin Rejuvenation and Anti-Aging

Skin rejuvenation represents the most extensively researched and commercially validated application of GHK-Cu. Multiple human studies have evaluated the peptide’s effects on aged or photoaged skin.

A controlled human study by Finkley et al. (2005) evaluated the effects of a GHK-Cu-containing cream applied to facial skin over 12 weeks. The study reported statistically significant improvements in skin density, thickness, and firmness compared to control, as measured by ultrasound imaging [9]. Participants also reported visible improvements in fine lines and overall skin texture.

A comparative study by Leyden et al. evaluated GHK-Cu cream against tretinoin (vitamin A) cream and vitamin C cream — two established topical anti-aging agents. The study reported that GHK-Cu cream performed comparably to tretinoin in improving skin laxity and overall appearance, and outperformed vitamin C cream on most measured parameters [10]. This is notable because tretinoin is considered one of the most effective topical anti-aging agents with decades of clinical validation.

Histological studies of skin treated with GHK-Cu have shown increased collagen production in the dermis, improved organisation of the extracellular matrix, and increased glycosaminoglycan content — structural changes consistent with a shift toward a more youthful skin phenotype [5].

Research also suggests that GHK-Cu may help protect skin from ultraviolet radiation damage. In vitro studies have shown that the peptide may reduce UV-induced MMP activation and support DNA repair mechanisms in keratinocytes [11]. These photoprotective properties may complement its direct anti-aging effects.

Wound Healing

GHK-Cu’s wound healing properties were among the earliest biological activities identified for this peptide, and they remain supported by a solid body of evidence.

Animal studies have demonstrated that GHK-Cu may accelerate wound closure, increase the formation of granulation tissue, improve angiogenesis at wound sites, and enhance the quality of wound repair. A study by Mulder et al. (1994) in a pig wound model found that wounds treated with GHK-Cu-containing matrices showed faster healing and improved tissue organisation compared to untreated controls [12].

The peptide’s effects on wound healing appear to involve multiple complementary mechanisms: enhanced cell migration to the wound site, increased collagen and glycosaminoglycan synthesis, improved angiogenesis providing blood supply to healing tissues, and modulated inflammation to support repair without excessive scarring.

Clinical applications of GHK-Cu in wound care have included its incorporation into wound dressings and matrices. Some commercial wound care products have utilised copper peptide technology, drawing on this research base.

Anti-Aging Beyond Skin

Beyond its well-documented effects on skin, research suggests that GHK-Cu may have broader anti-aging applications. The gene expression studies by Pickart et al. (2012) identified that many of the genes modulated by GHK-Cu are associated with age-related decline in tissue function across multiple organ systems [4].

Research indicates that GHK-Cu may support DNA repair mechanisms by upregulating genes involved in base excision repair and nucleotide excision repair pathways. Given that accumulated DNA damage is considered a hallmark of ageing, this activity could have implications beyond skin health, though this remains largely theoretical.

Studies also suggest that GHK-Cu may influence genes associated with oxidative stress response, mitochondrial function, and cellular senescence — processes considered central to biological ageing [4]. However, it is important to emphasise that these findings are primarily derived from gene expression analyses and cell culture studies. The practical anti-aging effects of systemic GHK-Cu administration in humans beyond topical skin applications have not been established through clinical trials.

Hair Growth

Research suggests that GHK-Cu may support hair growth through several mechanisms. The peptide’s ability to increase blood flow to follicles via angiogenesis, modulate DHT-related inflammatory signalling, and potentially stimulate dermal papilla cells has generated interest in hair loss applications.

In vitro studies have shown that GHK-Cu may increase the size of hair follicles and stimulate hair growth. Studies on hair transplant survival rates have also suggested that GHK-Cu may improve follicular unit viability when incorporated into preservation solutions [13].

Several commercial hair growth products contain copper peptides as active ingredients, and some dermatologists recommend GHK-Cu-containing topical products as adjunctive treatments for hair thinning. However, large-scale clinical trials specifically evaluating GHK-Cu for androgenetic alopecia or other forms of hair loss are lacking.

Dosage and Administration

Topical Application

Topical GHK-Cu is the most well-studied and widely used form. Commercial skincare products typically contain GHK-Cu at concentrations ranging from 0.01% to 1.0%, with most products in the 0.1% to 0.5% range.

• Concentration: Most research has used formulations containing 0.01-1% GHK-Cu
• Application frequency: Typically once or twice daily as part of a skincare routine
• Duration: Studies evaluating topical efficacy have typically run for 8-12 weeks, with continued use recommended for sustained effects

Topical GHK-Cu is generally well-suited for application to face, neck, decolletage, and hands — areas most affected by photoaging. It may be applied after cleansing and before heavier moisturisers or sunscreen.

Injectable (Subcutaneous)

Important: Injectable GHK-Cu protocols are not clinically validated and are based on community reports and extrapolations from research. Always consult a qualified healthcare provider.

Community-reported injectable protocols typically reference:

• Dosage: 1-2 mg per day, administered subcutaneously
• Frequency: Daily or 5 days per week
• Duration: 4-8 week cycles

Injectable GHK-Cu is supplied as a lyophilised powder requiring reconstitution with bacteriostatic water. Standard sterile technique should be followed, and reconstituted peptide should be stored refrigerated at 2-8 degrees Celsius.

It bears emphasis that while topical GHK-Cu has substantial research support, injectable protocols are far less studied and carry additional risks associated with injection.

Side Effects and Safety

GHK-Cu has a well-established safety profile for topical use, supported by decades of use in cosmetic products and multiple human studies. The safety profile for injectable use is less well characterised.

Topical safety:

• GHK-Cu is generally considered safe and well-tolerated as a topical cosmetic ingredient
• It is listed in the European Commission’s CosIng database as an approved cosmetic ingredient
• Allergic reactions are rare but possible, as with any topical ingredient
• Mild irritation may occur in individuals with very sensitive skin, particularly at higher concentrations
• Patch testing is recommended for individuals with a history of contact dermatitis

Community-reported side effects of injectable use (anecdotal, not clinically validated):

• Injection site redness, swelling, or discomfort
• Mild nausea
• Temporary skin flushing
• Headache
• Metallic taste (potentially related to the copper component)

Potential concerns and unknowns:

• Individuals with Wilson’s disease or other copper metabolism disorders should avoid GHK-Cu, as the copper component could exacerbate copper overload
• Long-term safety of injectable GHK-Cu has not been established
• Drug interactions have not been comprehensively studied, particularly for injectable forms
• Safety during pregnancy and lactation has not been established for injectable use — topical use at cosmetic concentrations is generally considered acceptable, but individuals should consult their healthcare provider
• While GHK-Cu has not been shown to promote cancer, the theoretical concern about growth factor stimulation applies, and individuals with active malignancies should consult their oncologist

Frequently Asked Questions

Is GHK-Cu better applied topically or by injection?

Topical GHK-Cu has significantly more research support and a well-established safety profile, making it the more evidence-based choice for skin-related applications. The small molecular weight of GHK-Cu (403.93 Da) allows reasonable skin penetration, which is one reason it has been successful as a cosmetic ingredient. Injectable GHK-Cu may theoretically provide higher systemic levels, but the clinical evidence for injectable use is extremely limited compared to topical application.

How does GHK-Cu compare to retinol or tretinoin?

A comparative study by Leyden et al. found that GHK-Cu cream performed comparably to tretinoin cream in improving skin laxity and appearance. However, tretinoin has a much larger body of clinical evidence spanning decades. GHK-Cu may be a reasonable option for individuals who cannot tolerate retinoids, which commonly cause dryness, peeling, and irritation. Many skincare professionals suggest that GHK-Cu and retinoids may be complementary when used at different times in a skincare routine.

Can GHK-Cu be combined with other peptides?

GHK-Cu is commonly combined with other skincare peptides such as palmitoyl pentapeptide (Matrixyl) in commercial formulations. For injectable protocols, some community protocols combine GHK-Cu with BPC-157 for injury recovery, though no clinical research has evaluated such combinations. As with any combination protocol, the safety and efficacy of multi-peptide approaches have not been established.

Why does GHK-Cu decline with age?

The mechanism behind the age-related decline in GHK-Cu levels is not fully understood. Plasma GHK-Cu drops from approximately 200 ng/mL at age 20 to approximately 80 ng/mL by age 60. This decline correlates with reduced tissue repair capacity and visible signs of ageing. Some researchers hypothesise that this decline may contribute to age-related impairment of wound healing, collagen maintenance, and antioxidant defence, though causation has not been definitively established.

Is GHK-Cu safe for sensitive skin?

Topical GHK-Cu is generally well-tolerated by most skin types, including sensitive skin. Unlike retinoids, it typically does not cause dryness, peeling, or photosensitivity. However, individuals with very reactive skin should start with lower concentrations and perform a patch test before broader application. Those with known copper allergies or sensitivities should avoid GHK-Cu products.

References

References

1. Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. 2008;19(8):969-988.
2. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2018;19(7):1987.
3. Borkow G. Using copper to improve the well-being of the skin. Current Chemical Biology. 2014;8(2):89-102.
4. Pickart L, et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International. 2015;2015:648108.
5. Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. 1988;238(2):343-346.
6. Siméon A, et al. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Journal of Investigative Dermatology. 2000;115(6):962-968.
7. Canapp SO, et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Veterinary Surgery. 2003;32(6):515-523.
8. Riordan NH, et al. Non-expanded adipose stromal vascular fraction cell therapy for common androgenetic alopecia. Journal of Translational Medicine. 2018;16(1):130.
9. Finkley MB, et al. The effect of copper peptide-containing facial cream on photoaged skin. Cosmetic Dermatology. 2005;18(7):471-476.
10. Leyden J, et al. Copper peptide and skin. Cosmetic Dermatology. 2002;15(5):29-33.
11. Jose S, et al. Photoprotective role of GHK-Cu in UV-induced oxidative stress in human keratinocytes. Photochemistry and Photobiology. 2017;93(2):439-445.
12. Mulder GD, et al. Enhanced healing of ulcers in patients treated with wound matrix and copper complex. Journal of the American Academy of Dermatology. 1994;31(2):359-364.
13. Pyo HK, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Archives of Pharmacal Research. 2007;30(7):834-839.

Continue Reading

Readers also explore

All peptides →

Recovery & Healing

BPC-157

Body Protection Compound-157

gut healing · tendon repair · wound healing

Open profile

Anti-Aging

Epitalon

Epithalon / Epithalone

anti-aging · telomere support · sleep regulation

Open profile